The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma

Laryngoscope

Volumn 115, Issue 2, 2005, Pages 237-243

  Nahas, Zayna ^d   Goldenberg, David ^a   Fakhry, Carol ^a   Ewertz, Marjorie ^b   Zeiger, Martha ^a   Ladenson, Paul W ^b   Wahl, Richard ^c   Tufano, Ralph P ^a,e  

^a Dept Otolaryngol Hd Neck Surg ^*

^b Division of Endocrinology   (United States)

^c Division of Nuclear Medicine   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Papillary thyroid carcinoma; Positron emission tomography with radiolabeled glucose analogue 2 flouro 2 deoxy D glucose; Positron emission tomography computed tomography

Indexed keywords

ADULT; AGED; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LARYNGOSCOPY; MALE; PAPILLARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER; RELIABILITY; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STANDARD; TECHNIQUE; THYROID CARCINOMA; TREATMENT PLANNING;

ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 13444301390     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000154725.00787.00     Document Type: Review

References (13)

1. Schlumberger M, Baudin E, Travagli JP. [Papillary and follicular cancers of the thyroid]. Presse Med 1998;27:1479-1481.
2. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999;9:421-427.
3. Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997;24:1342-1348.
4. Pachucki J, Burmeister LA. Evaluation and treatment of persistent thyroglobulinemia in patients with well-differentiated thyroid cancer. Eur J Endocrinol 1997;137:254-261.
5. Clark OH, Hoelting T. Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans. Thyroid 1994;4:501-505.
6. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 2003;97:90-96.
7. Frilling A, Tecklenborg K, Gorges R, Weber F, Clausen M, Broelsch EC. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg 2001;234:804-811.
8. Feine U. Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer. Eur J Endocrinol 1998;138:492-496.
9. Chung JK, So Y, Lee JS, et al. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 1999;40:986-992.
10. Altenvoerde G, Lerch H, Kuwert T, Matheja P, Schafers M, Schober O. Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg 1998;383:160-163.
11. Grunwald F, Schomburg A, Bender H, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1996;23:312-319.
12. Zimmer LA, McCook B, Meltzer C, et al. Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer. Otolaryngol Head Neck Surg 2003; 128:178-184.
13. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-1379.